|
1
|
Atkinson MA, Eisenbarth GS and Michels AW:
Type 1 diabetes. Lancet. 383:69–82. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Maahs DM, West NA, Lawrence JM and
Mayer-Davis EJ: Epidemiology of type 1 diabetes. Endocrinol Metab
Clin North Am. 39:481–497. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
de Ferranti SD, de Boer IH, Fonseca V, Fox
CS, Golden SH, Lavie CJ, Magge SN, Marx N, McGuire DK, Orchard TJ,
et al: Type 1 diabetes mellitus and cardiovascular disease: A
scientific statement from the American heart association and
American diabetes association. Diabetes Care. 37:2843–2863.
2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Forbes JM and Cooper ME: Mechanisms of
diabetic complications. Physiol Rev. 93:137–188. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gregory GA, Robinson TIG, Linklater SE,
Wang F, Colagiuri S, de Beaufort C and Donaghue KC: International
Diabetes Federation Diabetes Atlas Type 1 Diabetes in Adults
Special Interest Group. Magliano DJ, Maniam J, et al: Global
incidence, prevalence, and mortality of type 1 diabetes in 2021
with projection to 2040: A modelling study. Lancet Diabetes
Endocrinol. 10:741–760. 2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tell S, Nadeau KJ and Eckel RH: Lipid
management for cardiovascular risk reduction in type 1 diabetes.
Curr Opin Endocrinol Diabetes Obes. 27:207–214. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wang X, Pei J, Zheng K and Hu X:
High-density lipoprotein cholesterol levels are associated with
major adverse cardiovascular events in male but not female patients
with hypertension. Clin Cardiol. 44:723–730. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sniderman AD, Williams K, Contois JH,
Monroe HM, McQueen MJ, de Graaf J and Furberg CD: A meta-analysis
of low-density lipoprotein cholesterol, non-high-density
lipoprotein cholesterol, and apolipoprotein B as markers of
cardiovascular risk. Circ Cardiovasc Qual Outcomes. 4:337–345.
2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wu X and Xiao B: TDAG51 attenuates
impaired lipid metabolism and insulin resistance in gestational
diabetes mellitus through SREBP-1/ANGPTL8 pathway. Balkan Med J.
40:175–181. 2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Marques CL, Beretta MV, Prates RE, de
Almeida JC and da Costa Rodrigues T: Body adiposity markers and
insulin resistance in patients with type 1 diabetes. Arch
Endocrinol Metab. 67:401–407. 2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mero A: Leucine supplementation and
intensive training. Sports Med. 27:347–358. 1999.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Horman S, Browne G, Krause U, Patel J,
Vertommen D, Bertrand L, Lavoinne A, Hue L, Proud C and Rider M:
Activation of AMP-activated protein kinase leads to the
phosphorylation of elongation factor 2 and an inhibition of protein
synthesis. Curr Biol. 12:1419–1423. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang Y, Guo K, LeBlanc RE, Loh D,
Schwartz GJ and Yu YH: Increasing dietary leucine intake reduces
diet-induced obesity and improves glucose and cholesterol
metabolism in mice via multimechanisms. Diabetes. 56:1647–1654.
2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhang L, Li F, Guo Q, Duan Y, Wang W,
Zhong Y, Yang Y and Yin Y: Leucine supplementation: A novel
strategy for modulating lipid metabolism and energy homeostasis.
Nutrients. 12(1299)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bishop CA, Schulze MB, Klaus S and
Weitkunat K: The branched-chain amino acids valine and leucine have
differential effects on hepatic lipid metabolism. FASEB J.
34:9727–9739. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chaudhry ZZ, Morris DL, Moss DR, Sims EK,
Chiong Y, Kono T and Evans-Molina C: Streptozotocin is equally
diabetogenic whether administered to fed or fasted mice. Lab Anim.
47:257–265. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Jiao J, Han SF, Zhang W, Xu JY, Tong X,
Yin XB, Yuan LX and Qin LQ: Chronic leucine supplementation
improves lipid metabolism in C57BL/6J mice fed with a
high-fat/cholesterol diet. Food Nutr Res. 60(31304)2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang T, Fu X, Chen Q, Patra JK, Wang D,
Wang Z and Gai Z: Arachidonic acid metabolism and kidney
inflammation. Int J Mol Sci. 20(3683)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sears B and Perry M: The role of fatty
acids in insulin resistance. Lipids Health Dis.
14(121)2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Brun PJ, Yang KJZ, Lee SA, Yuen JJ and
Blaner WS: Retinoids: Potent regulators of metabolism. Biofactors.
39:151–163. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tentolouris N, Argyrakopoulou G and
Katsilambros N: Perturbed autonomic nervous system function in
metabolic syndrome. Neuromolecular Med. 10:169–178. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Vergès B: Pathophysiology of diabetic
dyslipidaemia: Where are we? Diabetologia. 58:886–899.
2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Rivera ME, Lyon ES, Johnson MA and Vaughan
RA: Leucine increases mitochondrial metabolism and lipid content
without altering insulin signaling in myotubes. Biochimie.
168:124–133. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fu L, Li F, Bruckbauer A, Cao Q, Cui X, Wu
R, Shi H, Xue B and Zemel MB: Interaction between leucine and
phosphodiesterase 5 inhibition in modulating insulin sensitivity
and lipid metabolism. Diabetes Metab Syndr Obes. 8:227–239.
2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Holowaty MNH, Lees MJ, Abou Sawan S,
Paulussen KJM, Jäger R, Purpura M, Paluska SA, Burd NA, Hodson N
and Moore DR: Leucine ingestion promotes mTOR translocation to the
periphery and enhances total and peripheral RPS6 phosphorylation in
human skeletal muscle. Amino Acids. 55:253–261. 2023.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Azzout-Marniche D: New insight into the
understanding of muscle glycolysis: Sestrins, key pivotal proteins
integrating glucose and leucine to control mTOR activation. J Nutr.
153:915–916. 2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cui C, Wu C, Wang J, Zheng X, Ma Z, Zhu P,
Guan W, Zhang S and Chen F: Leucine supplementation during late
gestation globally alters placental metabolism and nutrient
transport via modulation of the PI3K/AKT/mTOR signaling pathway in
sows. Food Funct. 13:2083–2097. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang MM, Guo HX, Huang YY, Liu WB, Wang X,
Xiao K, Xiong W, Hua HK, Li XF and Jiang GZ: Dietary leucine
supplementation improves muscle fiber growth and development by
activating AMPK/Sirt1 pathway in blunt snout bream (megalobrama
amblycephala). Aquac Nutr. 2022(7285851)2022.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Martin SB, Reiche WS, Fifelski NA, Schultz
AJ, Stanford SJ, Martin AA, Nack DL, Radlwimmer B, Boyer MP and
Ananieva EA: Leucine and branched-chain amino acid metabolism
contribute to the growth of bone sarcomas by regulating AMPK and
mTORC1 signaling. Biochem J. 477:1579–1599. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chen X, Xiang L, Jia G, Liu G, Zhao H and
Huang Z: Leucine regulates slow-twitch muscle fibers expression and
mitochondrial function by Sirt1/AMPK signaling in porcine skeletal
muscle satellite cells. Anim Sci J. 90:255–263. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Herzig S and Shaw RJ: AMPK: Guardian of
metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol.
19:121–135. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yun SY, Rim JH, Kang H, Lee SG and Lim JB:
Associations of LDL cholesterol, non-HDL cholesterol, and
apolipoprotein B with cardiovascular disease occurrence in adults:
Korean genome and epidemiology study. Ann Lab Med. 43:237–243.
2023.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lynch CJ and Adams SH: Branched-chain
amino acids in metabolic signalling and insulin resistance. Nat Rev
Endocrinol. 10:723–736. 2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
McCormack SE, Shaham O, McCarthy MA, Deik
AA, Wang TJ, Gerszten RE, Clish CB, Mootha VK, Grinspoon SK and
Fleischman A: Circulating branched-chain amino acid concentrations
are associated with obesity and future insulin resistance in
children and adolescents. Pediatr Obes. 8:52–61. 2013.PubMed/NCBI View Article : Google Scholar
|
